14 results · 23ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

Bio-Medicus Adult Cannulae and Introducer

FDA 510(k)
FDA Class 2 ·Cardiovascular

RHEUMATOID FACTOR IMMUNOLOGICAL TEST SYSTEM

FDA 510(k)
FDA Class 2 ·Immunology

ZODIAC POLYAXIAL SPINAL FIXATION SYSTEM

FDA 510(k)
FDA Class 2 ·Orthopedic

NSK

FDA Adverse Event
Injury ·NAKANISHI INC.·Product code EFB·May 27, 2024

NSK

FDA Adverse Event
Injury ·NAKANISHI INC.·Product code EFB·May 21, 2025

DIMENSION(R) CLINICAL CHEMISTRY SYSTEM

FDA Adverse Event
Malfunction ·SIEMENS HEALTHCARE DIAGNOSTICS INC - GLASGOW·Product code LCP·October 6, 2014

XIENCE XPEDITION EVEROLIMUS ELUTING CORONARY STENT SYSTEM

FDA Adverse Event
Malfunction ·AV-TEMECULA-CT·Product code NIQ·June 3, 2013

CONTOUR

FDA Adverse Event
Malfunction ·BAYER HEALTHCARE, LLC·Product code NBW·June 21, 2011

NSK

FDA Adverse Event
Injury ·NAKANISHI INC.·Product code EFB·December 21, 2016

NSK

FDA Adverse Event
Injury ·NAKANISHI INC.·Product code EFB·November 26, 2025

SLIDING MECHANISM

FDA Adverse Event
Malfunction ·SYNTHES BETTLACH·Product code HTD·August 31, 2016

Back up batteries in Ventilators labeled as the following: a. CARESCAPE R860 Ventilators (K142679) b. ENGSTROM (K111116) c. ENGSTROM Carestation (K111116) d. ENGSTROM PRO (K111116)

FDA Recall
Open, Classified ·GE Healthcare, LLC·Product code CBK·April 18, 2022

Back up batteries in Ventilators labeled as the following: a. CARESCAPE R860 Ventilators (K142679) b. ENGSTROM (K111116) c. ENGSTROM Carestation (K111116) d. ENGSTROM PRO (K111116)

FDA Enforcement
Class I ·Ongoing·GE Healthcare, LLC·June 15, 2022

BD FocalPoint Slide Profiler and BD FocalPoint GS Review Station; Catalog Nos. 490398, 490653, 491085, 491086, 491090, 490189 The BD FocalPoint GS Imaging System is intended to assist in cervical cancer screening of BD SurePath Liquid-based Pap Test slides to detect evidence of squamous carcinoma, adenocarcinoma and their usual precursor conditions.

FDA Enforcement
Class III ·Terminated·Becton Dickinson & Co.·October 17, 2018